Published

Long-term Amelioration of OCD Symptoms in a Patient with Chronic Consumption of Psilocybin-containing Mushrooms.

An abstract is available from the original source but is not redistributed by this tracker. Read the source record.

Open source BibTeX RIS

Bibliographic context

Journal: Journal of psychoactive drugs
Date: 2021-01-01
Source: PubMed
DOI: 10.1080/02791072.2020.1849879
PubMed: 33225874

Authors

Lugo-Radillo A Cortes-Lopez JL

Watch author

Derived topics and classifications

psilocybin OCD Receptor Pharmacology Other

Citation graph

0 referenced DOIs found in stored source metadata. 5 indexed papers cite this DOI.

Open citation network

Indexed papers citing this DOI

Revealing shortcomings in the assessment of psilocybin effects on OCD-related symptoms in preclinical and clinical studies: A systematic review2026-07-01 Case Report: Repeated low doses of psilocybin reduce perceived symptom severity but fail to restore cognitive flexibility in a case of severe obsessive-compulsive disorder: an observational case study of identical twins2026-04-21 Breaking the chains of depression: A systematic review and meta-analysis of psilocybin therapy2026-03-01 Addressing a major interference in the quantification of psilocin in mouse plasma: Development of a validated liquid chromatography tandem mass spectrometry method2024-08-01 Long-term Amelioration of OCD Symptoms in a Patient with Chronic Consumption of Psilocybin-containing Mushrooms.2021-01-01

Related papers

Neurotropic Effect of Extracts from the Hallucinogenic Mushroom Psilocybe cubensis (Earle) Sing. (Agaricomycetideae). In Vitro StudiesInternational journal of medicinal mushrooms · 2000-01-01 Novel qNMR Methodto Quantify Psilocybin and Psilocinin Psychedelic MushroomsFigshare · 2025-11-10 Naturally Derived Psilocybin for Therapeutic Use: A Six-Criterion Framework for Evidence, Safety, and Benefit-Risk Considerations in Policy and Clinical DevelopmentBiomolecules · 2026-07-03 DESI-MSI-Based Multi-Organ Distribution Mapping of Psilocin in ZebrafishMolecules · 2026-06-18 Regulatory ambiguity and governance challenges for psilocybin mushrooms in BrazilInternational Journal of Drug Policy · 2026-04-01 Quantitative LC-QToF-MS Analysis of Mycochemicals in Amanita muscaria, Psilocybe spp. (Agaricomycetes), and Consumer Products.International journal of medicinal mushrooms · 2025-01-01 Psilocybin Mushrooms and Public Health in Brazil: Insights from a Retrospective Analysis of Adverse Events and Their Implications for Regulatory Discussions.International journal of medicinal mushrooms · 2025-01-01 Psilocybin Conspectus: Status, Production Methods, and Considerations.International journal of medicinal mushrooms · 2022-01-01